The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure
- 8 November 2010
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 27 (1), 85-93
- https://doi.org/10.1002/dmrr.1155
Abstract
Background Diabetes and CHF are common comorbidities in hospitalized patients but the relationship between glycaemic control, glycaemic variability, and mortality in patients with both conditions is unclear. Methods We used administrative data to retrospectively identify patients with a diagnosis of CHF who underwent frequent glucose assessments. TWMG was compared with other measures of glycaemic control and a time‐weighted measure of glycaemic variability, the glycaemic lability index. The outcome was hospital mortality. Results A total of 748 patients were included in the final analysis. Time‐weighted mean glucose was higher than unadjusted mean glucose (137 + /− 44.7 mg/dL versus 167 + /− 54.9, p < 0.001), due in part to shorter sampling intervals at higher glucose levels. Hypoglycaemia, defined as a glucose level < 70 mg/dL, occurred during 6.3% of patient‐days in survivors and 8.4% of patient‐days among nonsurvivors (p = 0.05). Time‐weighted mean glucose was similar (128 + /− 33.1 mg/dL versus 138 + /− 45.1 mg/dL) in nonsurvivors versus survivors, p = 0.19). However, relatively few patients had were significantly elevated readings. Median GLI was higher in nonsurvivors compared with that in survivors (18.1 versus 6.82, p = 0.0003). Increasing glycaemic lability index (odds ratio 1.32, 95% confidence interval 1.05–1.65), and hypoglycaemia (odds ratio 2.21, 95% confidence interval 1.07–4.65), were independently associated with higher mortality in logistic regression analysis. Respiratory failure was associated with mortality, but not standard deviation of glucose. Conclusions Future studies analysing glycaemic control should control for variable sampling intervals. In this analysis, glycaemic lability index was independently associated with increased mortality, independent of hypoglycaemia. Prospective studies are needed to evaluate these findings. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality*Critical Care Medicine, 2010
- Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 DiabetesJAMA, 2006
- Diagnosing Diabetes and Preventing RehospitalizationsMedical Care, 2006
- Intensive Insulin Therapy in the Medical ICUThe New England Journal of Medicine, 2006
- An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failureAmerican Heart Journal, 2006
- Heart Failure in Diabetes mellitus: Clinical Features and Prognostic ImplicationsCardiology, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failureJournal of the American College of Cardiology, 2004
- American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic ControlEndocrine Practice, 2004
- Hyperglycaemic index as a tool to assess glucose control: a retrospective studyCritical Care, 2004